BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32037439)

  • 1. Predictors of venous thromboembolism development before and during chemotherapy for advanced germ cell tumor.
    Nitta S; Kawai K; Kimura T; Kawahara T; Kandori S; Hoshi A; Kojima T; Nishiyama H
    Jpn J Clin Oncol; 2020 Mar; 50(3):338-343. PubMed ID: 32037439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3).
    Tran B; Ruiz-Morales JM; Gonzalez-Billalabeitia E; Patrikidou A; Amir E; Seidel C; Bokemeyer C; Fankhauser C; Hermanns T; Rumyantsev A; Tryakin A; Brito M; Fléchon A; Kwan EM; Cheng T; Castellano D; Garcia Del Muro X; Hamid AA; Ottaviano M; Palmieri G; Kitson R; Reid A; Heng DYC; Bedard PL
    Cancer Med; 2020 Jan; 9(1):116-124. PubMed ID: 31715650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large retroperitoneal lymphadenopathy as a predictor of venous thromboembolism in patients with disseminated germ cell tumors treated with chemotherapy.
    Srikanthan A; Tran B; Beausoleil M; Jewett MA; Hamilton RJ; Sturgeon JF; O'Malley M; Anson-Cartwright L; Chung PW; Warde PR; Winquist E; Moore MJ; Amir E; Bedard PL
    J Clin Oncol; 2015 Feb; 33(6):582-7. PubMed ID: 25605848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolic events in germ cell cancer patients undergoing platinum-based chemotherapy.
    Honecker F; Koychev D; Luhmann AD; Langer F; Dieckmann KP; Bokemeyer C; Oechsle K
    Onkologie; 2013; 36(11):663-8. PubMed ID: 24192771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours.
    Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
    Eur J Cancer; 2016 Dec; 69():151-157. PubMed ID: 27821318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive Factors for Developing Venous Thrombosis during Cisplatin-Based Chemotherapy in Testicular Cancer.
    Heidegger I; Porres D; Veek N; Heidenreich A; Pfister D
    Urol Int; 2017; 99(1):104-109. PubMed ID: 28514776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
    Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
    World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
    Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
    BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
    Terbuch A; Walser G; Stotz M; Gerger A; Posch F; Bauernhofer T
    Clin Genitourin Cancer; 2023 Feb; 21(1):24-31. PubMed ID: 36400695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
    Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
    J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic Venous Thromboembolism is Associated with Inferior Survival among Patients Undergoing Nephrectomy with Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.
    Shah PH; Thompson RH; Boorjian SA; Lohse CM; Lyon TD; Shields RC; Froehling D; Leibovich BC; Viers BR
    J Urol; 2018 Sep; 200(3):520-527. PubMed ID: 29709665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted laparoscopic retroperitoneal lymph node dissection with concomitant inferior vena cava thrombectomy for metastatic mixed testicular germ cell cancer: a case report.
    Zhang K; Zhu G; Liu X; Tian J; Gu Y; Zhai M; Yang L; Liu W; Li H; Martinez Portillo FJ
    J Med Case Rep; 2019 Aug; 13(1):272. PubMed ID: 31451109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy.
    Solari L; Krönig M; Ihorst G; Drognitz K; Heinz J; Jilg CA; Schultze-Seemann W; Engelhardt M; Waller CF
    Urol Int; 2016; 96(4):399-405. PubMed ID: 27074038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of venous thromboembolic events in lymphoma.
    Zhou X; Teegala S; Huen A; Ji Y; Fayad L; Hagemeister FB; Gladish G; Vadhan-Raj S
    Am J Med; 2010 Oct; 123(10):935-41. PubMed ID: 20920696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prophylaxis of venous thromboembolism in extragonadal germ-cell tumour.
    Kubicek P; Boughalem E; Frere C;
    J Med Vasc; 2020 Apr; 45(2):90-92. PubMed ID: 32265022
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy.
    Ramos JD; Casey MF; Bamias A; De Giorgi U; Bellmunt J; Harshman LC; Ladoire S; Wong YN; Alva AS; Rosenberg JE; Galsky MD; Yu EY;
    Clin Appl Thromb Hemost; 2017 Oct; 23(7):755-760. PubMed ID: 27637910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cerebral Venous Sinus Thrombosis Following Cisplatin-Based Chemotherapy for Testicular Tumor].
    Ishihara M; Satoh K; Hanaoka M; Matsuzaki K; Matsuda T; Miyake H; Niki H
    No Shinkei Geka; 2017 May; 45(5):417-422. PubMed ID: 28490684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.